Home /
Chemotherapy – IST Istituto Nazionale per la Ricerca sul Cancro
|
|
| Description: |
| Patients: This study involved 11 patients with inoperable malignant pleural mesothelioma. None of the patients had been administered chemotherapy before.
Treatment: The treatment consisted of two chemotherapy drugs, oxaliplatin (eloxatin) and raltitrexed. Toxicity: Grade 3 or 4 toxicities included gastrointestinal, diarrhea, asthenia, neurotoxicity, and transaminase elevation. Results: Overall survival was not discussed, but the median time to progression (when the cancers grew) was 16.5 weeks. Correspondence: Dr. Roberto Maisano |
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."